DDS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
DDS is not a good buy right now for a Beginner with a long-term focus and $50,000-$100,000 to deploy. The stock is trending weakly, fundamentals are declining, analyst sentiment is mostly negative, and there is no bullish proprietary signal to override that. Based on the data, I would avoid buying now and prefer to sell or stay on the sidelines.
The chart setup is bearish. MACD histogram is -4.093 and still expanding lower, which confirms downward momentum. The moving averages are aligned bearishly with SMA_200 > SMA_20 > SMA_5, showing a weak trend structure. RSI_6 at 34.318 is near oversold but not a strong reversal signal. Price at 553.47 is essentially at S1 support of 553.739, which means it is testing support rather than breaking out. Overall, the technical trend remains negative.
There are only limited positives. UBS noted Dillard's may report a modest Q1 EPS beat and potentially improving same-store sales trends, which could support estimate revisions. The stock also appears to have some near-term support around the current level.
No news in the past week means no fresh catalyst to improve sentiment. Revenue, net income, EPS, and gross margin all declined in the latest quarter. Analysts remain cautious to bearish, with UBS, JPMorgan, and Telsey all maintaining negative or unimpressed stances. Hedge funds and insiders are neutral, and there is no recent congress or influential figure trading activity to support the stock. The broader trend is still weak, with expected near-term downside pressure in similar-pattern analysis.
In 2026/Q4, Dillard's showed declining fundamentals. Revenue fell 3.03% YoY to 1.989B, net income fell 4.96% YoY to 203.7M, EPS declined 3.19% YoY to 13.05, and gross margin slipped to 33.95%. This indicates the latest quarter season was weaker across sales, profitability, and margin quality.
Analyst sentiment is mixed but mostly negative. UBS raised its target to 465 but kept a Sell rating, JPMorgan cut its target to 449 and kept Underweight, and Telsey reduced its target to 650 while keeping Market Perform. The overall Wall Street view is cautious to bearish, with concerns about structural department store pressures and a challenging macro backdrop, even though some analysts expect a possible short-term earnings beat and slightly better same-store sales.
